AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mail
Get Alerts ANAB Hot Sheet
Join SI Premium – FREE
AnaptysBio, Inc. (NASDAQ: ANAB) reported Q2 EPS of $5.11, $5.24 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $27.5 million versus the consensus estimate of $20.22 million.
For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lockheed Martin (LMT) Tops Q3 EPS by 45c, Beats on Revenue; Offers FY26 Guidance
- Huntington Bancshares (HBAN) Tops Q3 EPS by 3c
- Honeywell (HON) Tops Q3 EPS by 11c; raises guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
